Clinical trial · Observational
Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients
NCT05377957CI-TRIAL-00108361PROQEMactive not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
PROQEM is a prospective cohort study among patients diagnosed with uveal melanoma to assess quality of life before and in the first five years after treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uveal Melanoma | Uveal Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Discrete choice experiment | Other | — | UNRESOLVED |
| Impact of side-effects analysis | Other | — | UNRESOLVED |
| Quality of life questionnaires | Other | — | UNRESOLVED |
| Shared decision-making analysis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Brachytherapy
- description
- Uveal melanoma patients treated with Ruthenium-106 plaque brachytherapy
- interventionNames
- Other: Quality of life questionnaires
- label
- Proton therapy
- description
- Uveal melanoma patients treated with proton therapy
- interventionNames
- Other: Quality of life questionnaires
- Other: Discrete choice experiment
- Other: Shared decision-making analysis
- Other: Impact of side-effects analysis
- label
- Enucleation
- description
- Uveal melanoma patients treated with enucleation
- interventionNames
- Other: Quality of life questionnaires
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥18 years * Clinical or pathological diagnosis of a melanoma of the choroid or ciliary body * No signs of metastasis after staging procedures with at least an X-thorax, blood test and an ultrasound of the liver * Treatment by brachytherapy, proton therapy or enucleation Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.